


<!DOCTYPE html>
<html lang="en">
<head><script src="//archive.org/includes/analytics.js?v=cf34f82" type="text/javascript"></script>
<script type="text/javascript">window.addEventListener('DOMContentLoaded',function(){var v=archive_analytics.values;v.service='wb';v.server_name='wwwb-app23.us.archive.org';v.server_ms=602;archive_analytics.send_pageview({});});</script><script type="text/javascript" src="/static/js/wbhack.js?v=1531166943.0" charset="utf-8"></script>

<script type="text/javascript">
__wbhack.init('https://web.archive.org/web');
</script>
<link rel="stylesheet" type="text/css" href="/static/css/banner-styles.css?v=1531166943.0" />
<link rel="stylesheet" type="text/css" href="/static/css/iconochive.css?v=1531166943.0" />

<!-- End Wayback Rewrite JS Include -->  

        <title>Inherited thrombophilias in pregnancy. | National Guideline Clearinghouse</title>

    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width">
    <link rel="icon" href="/web/20180712210216im_/https://www.guideline.gov/UI/images/favicon-NGC.ico">
    <link rel="apple-touch-icon" sizes="180x180" href="/web/20180712210216im_/https://www.guideline.gov/UI/images/apple-touch-icon-NGC.png">
    <link rel="icon" type="image/png" href="/web/20180712210216im_/https://www.guideline.gov/UI/images/favicon-NGC-32x32.png" sizes="32x32">
    <link rel="icon" type="image/png" href="/web/20180712210216im_/https://www.guideline.gov/UI/images/favicon-NGC-16x16.png" sizes="16x16">
    <link rel="manifest" href="/web/20180712210216/https://www.guideline.gov/UI/images/manifest-NGC.json">
    <link rel="mask-icon" href="/web/20180712210216im_/https://www.guideline.gov/UI/images/safari-pinned-tab-NGC.svg" color="#1d4345">
    <meta name="theme-color" content="#ffffff">
    
<link href="/web/20180712210216cs_/https://www.guideline.gov/cassette.axd/stylesheet/8382974d7bae1577062376dcd37102348398fe04/NGCSiteCSS" type="text/css" rel="stylesheet"/>
<!--[if lt IE 9]>
<link href="/cassette.axd/stylesheet/2188ac5b8507764bb4079068f7a3c8d7ccfba0e7/ieCSS" type="text/css" rel="stylesheet"/>
<![endif]-->



    <script async type="text/javascript" id="_fed_an_ua_tag" src="https://web.archive.org/web/20180712210216js_/https://dap.digitalgov.gov/Universal­-Federated-­Analytics-­Min.js?agency=HHS&amp;subagency=AHRQ"></script>
    </head>
<body class="no-js content-page">
<a href="#main-content" id="skip-nav">Skip to main content</a>
<!--https://developers.google.com/tag-manager/devguide#multidomain  ECH-1199-->
    
    <!-- Google Tag Manager -->
    <noscript>
        <iframe src="//web.archive.org/web/20180712210216if_/https://www.googletagmanager.com/ns.html?id=GTM-W4NX5V" height="0" width="0" style="display:none;visibility:hidden"></iframe>
    </noscript>
    <script>
        (function (w, d, s, l, i) {
            w[l] = w[l] || []; w[l].push({
                'gtm.start':
                new Date().getTime(), event: 'gtm.js'
            }); var f = d.getElementsByTagName(s)[0],
            j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src =
            '//web.archive.org/web/20180712210216/https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f);
        })(window, document, 'script', 'dataLayer', 'GTM-W4NX5V');</script>

    <noscript>
        <iframe src="//web.archive.org/web/20180712210216if_/https://www.googletagmanager.com/ns.html?id=GTM-KHDP6Z" height="0" width="0" style="display:none;visibility:hidden"></iframe>
    </noscript>
    <script>
        (function (w, d, s, l, i) {
            w[l] = w[l] || []; w[l].push({
                'gtm.start':
                new Date().getTime(), event: 'gtm.js'
            }); var f = d.getElementsByTagName(s)[0],
            j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src =
            '//web.archive.org/web/20180712210216/https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f);
        })(window, document, 'script', 'dataLayer', 'GTM-KHDP6Z');</script>
    <!-- End Google Tag Manager -->


    <!-- AHRQ HEADER -->
<div id="ahrq-header">

	<p class="hhs-links">
		<a href="https://web.archive.org/web/20180712210216/http://www.hhs.gov/" target="_blank" class="logo-hhs"><span class="logomark"></span>U.S.&nbsp;Department of&nbsp;Health&nbsp;and Human&nbsp;Services</a>
		<a href="https://web.archive.org/web/20180712210216/http://www.hhs.gov/" target="_blank" class="external-link"><strong>HHS.gov</strong></a>
	</p><!-- /.hhs-links -->
	<p class="ahrq-links">
		<a href="https://web.archive.org/web/20180712210216/http://www.ahrq.gov/" target="_blank" class="logo-ahrq">Agency for Healthcare Research and Quality: Advancing Excellence in Health Care</a>
		<a href="https://web.archive.org/web/20180712210216/http://www.ahrq.gov/" target="_blank" class="external-link"><strong>AHRQ.gov</strong></a>
	</p><!-- /.ahrq-links -->

</div><!-- /#ahrq-header -->

	<!-- HEADER -->
	<div class="header" id="header">
		<div class="masthead">

			<ul class="header-actions">
				<li><a href="#header-search" class="search-action"><span class="label">Search</span></a></li>
				<li><a href="#header-account" class="account-action"><span class="label">Account</span></a></li>
				<li><a href="#main-nav" class="menu-action"><span class="label">Menu</span></a></li>
			</ul><!-- /.header-actions -->
				
				<a href="/web/20180712210216/https://www.guideline.gov/" class="header-logo NGC">
				    <picture>
				        <source media="(min-width: 960px)" srcset="/web/20180712210216im_/https://www.guideline.gov/UI/images/logo_NGC_header.png">
				        <source srcset="/web/20180712210216im_/https://www.guideline.gov/UI/images/logo_NGC_header_m.png">
				        <img src="/web/20180712210216im_/https://www.guideline.gov/UI/images/logo_NGC_header.png" alt="National Guideline Clearinghouse">
				    </picture>
				</a>
<form action="/web/20180712210216/https://www.guideline.gov/search" class="header-search header-action" enctype="multipart/form-data" id="header-search" method="get">					<p class="search-bar">
						<label for="q"><span class="screen-reader-text">Search</span>
							<input id="q" type="text" title="Search Input" name="q" class="search-input" placeholder="Search">
						</label>
						<input id="masthead-search-button" type="submit" title="Search Submit" class="search-submit" value="Search">
					</p>
					<p class="search-tips">
						<a href="/web/20180712210216/https://www.guideline.gov/help-and-about/search-browse/search-tips">Search Tips</a>
					</p>
</form>				<div class="header-account header-action" id="header-account">
				<a id="login-button" class="signin" href="/web/20180712210216/https://www.guideline.gov/accounts/signinlanding" aria-role="tab" aria-controls="login-panel" aria-selected="false">Log into My NGC</a>
<div id="login-panel" class="login dropdown" aria-role="tab-panel" aria-labeledby="login-button" aria-hidden="true">
    
            <div class="sign-in">
            <form id="sign-in-form" action="/web/20180712210216/https://www.guideline.gov/Accounts/LoginSubmit" method="post">
                <h3>Sign In</h3>
                <div class="errormessages"></div>
                <p class="invalid-user-cred message-block" style="display: none;"></p>
                <p>
                    <label for="sign-in-username">Username or Email <span class="required">*</span></label>
                    <input type="text" id="sign-in-username" class="input-text" name="email" required>
                   
                </p>
                <p>
                    <label for="sign-in-userpwd">Password <span class="required">*</span></label>
                    <input type="password" id="sign-in-userpwd" class="input-text" name="password" required>
                  
                </p>
                <p class="form-link"><a href="/web/20180712210216/https://www.guideline.gov/accounts/forgotpassword">Forgot Password?</a></p>
                <p><label for="remember-me"><input type="checkbox" name="remember-me" id="remember-me">Remember Me</label></p>
                <input id="account-sign-in" type="submit" value="Sign In"/>
            </form>
            <p>
                <label for="sign-up-btn">Don't have an account?</label>
                <a href="/web/20180712210216/https://www.guideline.gov/accounts/login" class="sign-up-btn" id="sign-up-btn">Create New Account</a>
            </p>
        </div><!--/.sign-in-->
</div><!-- /.login -->
				</div><!-- /.header-account -->
		</div><!-- /.masthead -->

		<div class="main-nav header-action" id="main-nav">
		    <ul class="level-1">
		        <li class=""><a href="/web/20180712210216/https://www.guideline.gov/">Home</a></li>
		        <li class=""><a href="/web/20180712210216/https://www.guideline.gov/new-this-week/index">New This Week</a></li>
		        <li>
<a href="/web/20180712210216/https://www.guideline.gov/summaries/browse" class="parent-link">Guideline Summaries</a>                    		            <ul class="level-2 dropdown">
                             <li class=""><a href="/web/20180712210216/https://www.guideline.gov/browse/clinical-specialty">By Clinical Specialty</a></li>
		                <li class=""><a href="/web/20180712210216/https://www.guideline.gov/browse/organization">By Organization</a></li>
		                <li class=""><a href="/web/20180712210216/https://www.guideline.gov/browse/mesh-tag">By MeSH Tag</a></li>
		                <li class=""><a href="/web/20180712210216/https://www.guideline.gov/summaries/in-progress">In Progress</a></li>
		                <li class=""><a href="/web/20180712210216/https://www.guideline.gov/summaries/archive">Archive</a></li>

		                <li class=""><a href="/web/20180712210216/https://www.guideline.gov/search?f_DocType=0&amp;fLockTerm=Guideline Summaries">All Summaries</a></li>
		            </ul>
		        </li>
<li class=""><a href="/web/20180712210216/https://www.guideline.gov/syntheses/index">Guideline Syntheses</a></li>		        <li class=""><a href="/web/20180712210216/https://www.guideline.gov/expert">Expert Commentaries</a></li>
		        <li class=""><a href="/web/20180712210216/https://www.guideline.gov/matrix">Matrix Tool</a></li>
		        <li class="">
<a href="/web/20180712210216/https://www.guideline.gov/summaries/submit">Submit Guidelines</a>                    		        </li>
                <li class=""><a href="/web/20180712210216/https://www.guideline.gov/help-and-about">Help &amp;&nbsp;About</a></li>		      
		    </ul>
		</div><!-- /.main-nav -->
</div><!-- /.header -->

    <br/><div class="content"><div class="fundingNotice2"><b>The AHRQ National Guideline Clearinghouse (NGC, guideline.gov) Web site will not be available after July 16, 2018</b> because federal funding <br/>through AHRQ will no longer be available to support the NGC as of that date. For additional information, read our <a href="/web/20180712210216/https://www.guideline.gov/home/announcements">full announcement</a>.</div></div>

	<!-- CONTENT -->
	<main id="main-content" tabindex="-1">
		

<div class="main">

		<div class="aside-container">

	<div class="content">

    <!-- CONTENT HEADER -->
    <div class="content-header">
        <ul class="content-header-meta">
            <li class="prefix-icon guideline">Guideline Summary</li>
            <li>NGC:009990</li>
            <li>2010 Apr (revised 2013 Sep)
            </li>            
                                </ul>
        <div>
                <h1>Inherited thrombophilias in pregnancy.</h1>
        </div>
    </div>
    <!-- /.content-header-meta -->

        <!-- CONTENT TABS -->
        <ul class="content-tabs">
            <li><a href="#developer-tab" class="developer is-active"><span class="label">Developer</span></a></li>
            <li><a href="#source-tab" class="source"><span class="label">Source</span></a></li>
            <li><a href="#status-tab" class="status"><span class="label">Status</span></a></li>
            <li><a href="#classification-tab" class="classification"><span class="label">Classification</span></a></li>
        </ul>
        <div id="developer-tab" class="is-active content-tab-panel">
                <ul class="developer-list">
        <li><a href="/web/20180712210216/https://www.guideline.gov/search?f_Guideline_Developer_String=American%20College%20of%20Obstetricians%20and%20Gynecologists&amp;fLockTerm=American%2BCollege%2Bof%2BObstetricians%2Band%2BGynecologists">American College of Obstetricians and Gynecologists</a></li>
                        <li>   
                                <a id="85" href="#" data-alert="SignInLanding" data-alert-type="organization" class="get-alerts get-org-alerts">Get Alerts</a>
                        </li>
                </ul>
        </div>
    <!-- /.content-tab-panel -->
    <div id="source-tab" class="content-tab-panel">
<table><tr><td>American College of Obstetricians and Gynecologists (ACOG). Inherited thrombophilias in pregnancy. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 2013 Sep. 12 p.&nbsp;(ACOG practice bulletin; no. 138).&nbsp; [69 references]</td></tr></table>            </div>
    <!-- /.content-tab-panel -->
    <div id="status-tab" class="content-tab-panel">
            <p><div class="content_para"><p>This is the current release of the guideline.</p>
<p>This guideline updates a previous version: American College of Obstetricians and Gynecologists (ACOG). Inherited thrombophilias in pregnancy. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 2011 Sep. 11 p. (ACOG practice bulletin; no. 124). [66 references]</p></div></p>
    </div>
    <!-- /.content-tab-panel -->
    <div id="classification-tab" class="content-tab-panel">


        
                    <h4>Age Group</h4>
            <ul>
                        <li><a href="/web/20180712210216/https://www.guideline.gov/search?f_Age_of_Target_Population=Adolescent%20%2813%20to%2018%20years%29&amp;fLockTerm=Adolescent%2B%2813%2Bto%2B18%2Byears%29">Adolescent (13 to 18 years)</a></li>                      
                        <li><a href="/web/20180712210216/https://www.guideline.gov/search?f_Age_of_Target_Population=Adult%20%2819%20to%2044%20years%29&amp;fLockTerm=Adult%2B%2819%2Bto%2B44%2Byears%29">Adult (19 to 44 years)</a></li>                      
            </ul>
                    <h4>UMLS Concepts <a href="/web/20180712210216/https://www.guideline.gov/help-and-about/search-browse/umls-concepts" class="what-is">(what is this?)</a></h4>
                <div class="field">
                    <h5 class="field-label">ICD9CM</h5>
                    <div class="field-content">
<a href="/web/20180712210216/https://www.guideline.gov/search?f_ICD9CM_CUI=C1719583&amp;fLockTerm=Coagulation+defects+complicating+pregnancy%2c+childbirth%2c+or+the+puerperium%2c+antepartum+condition+or+complication">Coagulation defects complicating pregnancy, childbirth, or the puerperium, antepartum condition or complication</a>
 (649.33), <a href="/web/20180712210216/https://www.guideline.gov/search?f_ICD9CM_CUI=C0009699&amp;fLockTerm=Congenital+deficiency+of+other+clotting+factors">Congenital deficiency of other clotting factors</a>
 (286.3), <a href="/web/20180712210216/https://www.guideline.gov/search?f_ICD9CM_CUI=C0040038&amp;fLockTerm=Other+venous+embolism+and+thrombosis+of+unspecified+site">Other venous embolism and thrombosis of unspecified site</a>
 (453.9)                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">MSH</h5>
                    <div class="field-content">
<a href="/web/20180712210216/https://www.guideline.gov/search?f_MSH_CUI=C0003280&amp;fLockTerm=Anticoagulants">Anticoagulants</a>
, <a href="/web/20180712210216/https://www.guideline.gov/search?f_MSH_CUI=C0272375&amp;fLockTerm=Antithrombin+III+Deficiency">Antithrombin III Deficiency</a>
, <a href="/web/20180712210216/https://www.guideline.gov/search?f_MSH_CUI=C0852077&amp;fLockTerm=Blood+Coagulation+Disorders%2c+Inherited">Blood Coagulation Disorders, Inherited</a>
, <a href="/web/20180712210216/https://www.guideline.gov/search?f_MSH_CUI=C0016018&amp;fLockTerm=Fibrinolytic+Agents">Fibrinolytic Agents</a>
, <a href="/web/20180712210216/https://www.guideline.gov/search?f_MSH_CUI=C0679560&amp;fLockTerm=Genetic+Testing">Genetic Testing</a>
, <a href="/web/20180712210216/https://www.guideline.gov/search?f_MSH_CUI=C0019134&amp;fLockTerm=Heparin">Heparin</a>
, <a href="/web/20180712210216/https://www.guideline.gov/search?f_MSH_CUI=C0019139&amp;fLockTerm=Heparin%2c+Low-Molecular-Weight">Heparin, Low-Molecular-Weight</a>
, <a href="/web/20180712210216/https://www.guideline.gov/search?f_MSH_CUI=C1449835&amp;fLockTerm=Intermittent+Pneumatic+Compression+Devices">Intermittent Pneumatic Compression Devices</a>
, <a href="/web/20180712210216/https://www.guideline.gov/search?f_MSH_CUI=C0525032&amp;fLockTerm=International+Normalized+Ratio">International Normalized Ratio</a>
, <a href="/web/20180712210216/https://www.guideline.gov/search?f_MSH_CUI=C0025084&amp;fLockTerm=Medical+History+Taking">Medical History Taking</a>
, <a href="/web/20180712210216/https://www.guideline.gov/search?f_MSH_CUI=C0026882&amp;fLockTerm=Mutation">Mutation</a>
, <a href="/web/20180712210216/https://www.guideline.gov/search?f_MSH_CUI=C0032961&amp;fLockTerm=Pregnancy">Pregnancy</a>
, <a href="/web/20180712210216/https://www.guideline.gov/search?f_MSH_CUI=C0032962&amp;fLockTerm=Pregnancy+Complications">Pregnancy Complications</a>
, <a href="/web/20180712210216/https://www.guideline.gov/search?f_MSH_CUI=C0032964&amp;fLockTerm=Pregnancy+Complications%2c+Hematologic">Pregnancy Complications, Hematologic</a>
, <a href="/web/20180712210216/https://www.guideline.gov/search?f_MSH_CUI=C0032972&amp;fLockTerm=Pregnancy+Outcome">Pregnancy Outcome</a>
, <a href="/web/20180712210216/https://www.guideline.gov/search?f_MSH_CUI=C0398625&amp;fLockTerm=Protein+C+Deficiency">Protein C Deficiency</a>
, <a href="/web/20180712210216/https://www.guideline.gov/search?f_MSH_CUI=C0242666&amp;fLockTerm=Protein+S+Deficiency">Protein S Deficiency</a>
, <a href="/web/20180712210216/https://www.guideline.gov/search?f_MSH_CUI=C0038348&amp;fLockTerm=Stockings%2c+Compression">Stockings, Compression</a>
, <a href="/web/20180712210216/https://www.guideline.gov/search?f_MSH_CUI=C0040038&amp;fLockTerm=Thromboembolism">Thromboembolism</a>
, <a href="/web/20180712210216/https://www.guideline.gov/search?f_MSH_CUI=C0040044&amp;fLockTerm=Thrombolytic+Therapy">Thrombolytic Therapy</a>
, <a href="/web/20180712210216/https://www.guideline.gov/search?f_MSH_CUI=C0398623&amp;fLockTerm=Thrombophilia">Thrombophilia</a>
, <a href="/web/20180712210216/https://www.guideline.gov/search?f_MSH_CUI=C1861172&amp;fLockTerm=Venous+Thromboembolism">Venous Thromboembolism</a>
, <a href="/web/20180712210216/https://www.guideline.gov/search?f_MSH_CUI=C0043031&amp;fLockTerm=Warfarin">Warfarin</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">MTH</h5>
                    <div class="field-content">
<a href="/web/20180712210216/https://www.guideline.gov/search?f_MTH_CUI=C0003280&amp;fLockTerm=Anticoagulants">Anticoagulants</a>
, <a href="/web/20180712210216/https://www.guideline.gov/search?f_MTH_CUI=C0272375&amp;fLockTerm=Antithrombin+III+Deficiency">Antithrombin III Deficiency</a>
, <a href="/web/20180712210216/https://www.guideline.gov/search?f_MTH_CUI=C0038348&amp;fLockTerm=Compression+Stockings">Compression Stockings</a>
, <a href="/web/20180712210216/https://www.guideline.gov/search?f_MTH_CUI=C0584960&amp;fLockTerm=Factor+V+Leiden+mutation">Factor V Leiden mutation</a>
, <a href="/web/20180712210216/https://www.guideline.gov/search?f_MTH_CUI=C0016018&amp;fLockTerm=Fibrinolytic+Agents">Fibrinolytic Agents</a>
, <a href="/web/20180712210216/https://www.guideline.gov/search?f_MTH_CUI=C0679560&amp;fLockTerm=Genetic+screening+method">Genetic screening method</a>
, <a href="/web/20180712210216/https://www.guideline.gov/search?f_MTH_CUI=C0019134&amp;fLockTerm=Heparin">Heparin</a>
, <a href="/web/20180712210216/https://www.guideline.gov/search?f_MTH_CUI=C0019139&amp;fLockTerm=Heparin%2c+Low-Molecular-Weight">Heparin, Low-Molecular-Weight</a>
, <a href="/web/20180712210216/https://www.guideline.gov/search?f_MTH_CUI=C0525032&amp;fLockTerm=International+Normalized+Ratio">International Normalized Ratio</a>
, <a href="/web/20180712210216/https://www.guideline.gov/search?f_MTH_CUI=C0733511&amp;fLockTerm=Medical+Surveillance">Medical Surveillance</a>
, <a href="/web/20180712210216/https://www.guideline.gov/search?f_MTH_CUI=C1856061&amp;fLockTerm=Methylenetetrahydrofolate+reductase+deficiency">Methylenetetrahydrofolate reductase deficiency</a>
, <a href="/web/20180712210216/https://www.guideline.gov/search?f_MTH_CUI=C0026882&amp;fLockTerm=Mutation">Mutation</a>
, <a href="/web/20180712210216/https://www.guideline.gov/search?f_MTH_CUI=C0032961&amp;fLockTerm=Pregnancy">Pregnancy</a>
, <a href="/web/20180712210216/https://www.guideline.gov/search?f_MTH_CUI=C0032962&amp;fLockTerm=Pregnancy+Complications">Pregnancy Complications</a>
, <a href="/web/20180712210216/https://www.guideline.gov/search?f_MTH_CUI=C0086930&amp;fLockTerm=Risk+Assessment">Risk Assessment</a>
, <a href="/web/20180712210216/https://www.guideline.gov/search?f_MTH_CUI=C0040038&amp;fLockTerm=Thromboembolism">Thromboembolism</a>
, <a href="/web/20180712210216/https://www.guideline.gov/search?f_MTH_CUI=C0398623&amp;fLockTerm=Thrombophilia">Thrombophilia</a>
, <a href="/web/20180712210216/https://www.guideline.gov/search?f_MTH_CUI=C1861172&amp;fLockTerm=Venous+Thromboembolism">Venous Thromboembolism</a>
, <a href="/web/20180712210216/https://www.guideline.gov/search?f_MTH_CUI=C0043031&amp;fLockTerm=Warfarin">Warfarin</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">PDQ</h5>
                    <div class="field-content">
<a href="/web/20180712210216/https://www.guideline.gov/search?f_PDQ_CUI=C0019134&amp;fLockTerm=heparin">heparin</a>
, <a href="/web/20180712210216/https://www.guideline.gov/search?f_PDQ_CUI=C0040038&amp;fLockTerm=thromboembolism">thromboembolism</a>
, <a href="/web/20180712210216/https://www.guideline.gov/search?f_PDQ_CUI=C0040044&amp;fLockTerm=thrombolytic+therapy">thrombolytic therapy</a>
, <a href="/web/20180712210216/https://www.guideline.gov/search?f_PDQ_CUI=C0043031&amp;fLockTerm=warfarin">warfarin</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">SNOMEDCT_US</h5>
                    <div class="field-content">
<a href="/web/20180712210216/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0003280&amp;fLockTerm=Anticoagulant">Anticoagulant</a>
 (372862008), <a href="/web/20180712210216/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0003280&amp;fLockTerm=Anticoagulant">Anticoagulant</a>
 (81839001), <a href="/web/20180712210216/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0272375&amp;fLockTerm=Antithrombin+III+deficiency">Antithrombin III deficiency</a>
 (36351005), <a href="/web/20180712210216/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0038348&amp;fLockTerm=Compression+stocking">Compression stocking</a>
 (348681001), <a href="/web/20180712210216/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0038348&amp;fLockTerm=Compression+stocking">Compression stocking</a>
 (467848007), <a href="/web/20180712210216/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0456888&amp;fLockTerm=f+-+Family+history">f - Family history</a>
 (277652007), <a href="/web/20180712210216/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0584960&amp;fLockTerm=Factor+V+Leiden+mutation">Factor V Leiden mutation</a>
 (307091009), <a href="/web/20180712210216/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0026882&amp;fLockTerm=Genetic+mutation">Genetic mutation</a>
 (55446002), <a href="/web/20180712210216/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0679560&amp;fLockTerm=Genetic+test">Genetic test</a>
 (405824009), <a href="/web/20180712210216/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0019134&amp;fLockTerm=Heparin">Heparin</a>
 (372877000), <a href="/web/20180712210216/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0019134&amp;fLockTerm=Heparin">Heparin</a>
 (84812008), <a href="/web/20180712210216/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0019134&amp;fLockTerm=Heparin">Heparin</a>
 (96382006), <a href="/web/20180712210216/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C1449835&amp;fLockTerm=Intermittent+pneumatic+compression+device">Intermittent pneumatic compression device</a>
 (432441000124100), <a href="/web/20180712210216/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0525032&amp;fLockTerm=International+normalized+ratio">International normalized ratio</a>
 (165581004), <a href="/web/20180712210216/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0525032&amp;fLockTerm=International+normalized+ratio">International normalized ratio</a>
 (1951000175101), <a href="/web/20180712210216/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0019139&amp;fLockTerm=Low+molecular+weight+heparin">Low molecular weight heparin</a>
 (373294004), <a href="/web/20180712210216/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0019139&amp;fLockTerm=Low+molecular+weight+heparin">Low molecular weight heparin</a>
 (87233003), <a href="/web/20180712210216/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0032961&amp;fLockTerm=Pregnancy">Pregnancy</a>
 (289908002), <a href="/web/20180712210216/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0398625&amp;fLockTerm=Protein+C+deficiency+disease">Protein C deficiency disease</a>
 (76407009), <a href="/web/20180712210216/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0242666&amp;fLockTerm=Protein+S+deficiency+disease">Protein S deficiency disease</a>
 (1563006), <a href="/web/20180712210216/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C2584409&amp;fLockTerm=Prothrombin+G20210A+mutation">Prothrombin G20210A mutation</a>
 (440989002), <a href="/web/20180712210216/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0086930&amp;fLockTerm=Risk+assessment">Risk assessment</a>
 (225338004), <a href="/web/20180712210216/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0733511&amp;fLockTerm=Surveillance">Surveillance</a>
 (225419007), <a href="/web/20180712210216/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0040038&amp;fLockTerm=Thromboembolic+disorder">Thromboembolic disorder</a>
 (13713005), <a href="/web/20180712210216/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0040038&amp;fLockTerm=Thromboembolic+disorder">Thromboembolic disorder</a>
 (371039008), <a href="/web/20180712210216/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C1997614&amp;fLockTerm=Thromboembolism+of+vein">Thromboembolism of vein</a>
 (429098002), <a href="/web/20180712210216/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0016018&amp;fLockTerm=Thrombolytic">Thrombolytic</a>
 (303960004), <a href="/web/20180712210216/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0016018&amp;fLockTerm=Thrombolytic">Thrombolytic</a>
 (372742009), <a href="/web/20180712210216/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0040044&amp;fLockTerm=Thrombolytic+therapy">Thrombolytic therapy</a>
 (426347000), <a href="/web/20180712210216/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0398623&amp;fLockTerm=Thrombophilia">Thrombophilia</a>
 (234467004), <a href="/web/20180712210216/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0398623&amp;fLockTerm=Thrombophilia">Thrombophilia</a>
 (76612001), <a href="/web/20180712210216/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C1277720&amp;fLockTerm=Thrombophilia+screening">Thrombophilia screening</a>
 (165598004), <a href="/web/20180712210216/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C1277720&amp;fLockTerm=Thrombophilia+screening">Thrombophilia screening</a>
 (314089003), <a href="/web/20180712210216/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0043031&amp;fLockTerm=Warfarin">Warfarin</a>
 (372756006), <a href="/web/20180712210216/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0043031&amp;fLockTerm=Warfarin">Warfarin</a>
 (48603004)                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">SPN</h5>
                    <div class="field-content">
<a href="/web/20180712210216/https://www.guideline.gov/search?f_SPN_CUI=C0019134&amp;fLockTerm=HEPARIN">HEPARIN</a>
, <a href="/web/20180712210216/https://www.guideline.gov/search?f_SPN_CUI=C0038348&amp;fLockTerm=STOCKING%2c+MEDICAL+SUPPORT+(FOR+GENERAL+MEDICAL+PURPOSES)">STOCKING, MEDICAL SUPPORT (FOR GENERAL MEDICAL PURPOSES)</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">UMD</h5>
                    <div class="field-content">
<a href="/web/20180712210216/https://www.guideline.gov/search?f_UMD_CUI=C0038348&amp;fLockTerm=Socks%2fStockings%2c+Elastic+Compression">Socks/Stockings, Elastic Compression</a>
 (13-789)                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
    </div>
        <!-- /.content-tab-panel -->
        <!-- /.content-tab-panel -->
        <!-- TOOLBAR -->
        <div class="content-toolbar">

            <!-- Primary -->
            <ul class="tools primary-tools">
                <li class="dropdown tool sections">
                    <a href="#" class="tool-button">Sections</a>
                    <div class="dropdown-panel">
                            <ul class="section-links">
                                    <li><a href="#420" class="section-mark">Recommendations</a></li>
                                    <li><a href="#396" class="section-mark">Scope</a></li>
                                    <li><a href="#405" class="section-mark">Methodology</a></li>
                                    <li><a href="#424" class="section-mark">Evidence Supporting the Recommendations</a></li>
                                    <li><a href="#427" class="section-mark">Benefits/Harms of Implementing the Guideline Recommendations</a></li>
                                    <li><a href="#432" class="section-mark">Qualifying Statements</a></li>
                                    <li><a href="#434" class="section-mark">Implementation of the Guideline</a></li>
                                    <li><a href="#439" class="section-mark">Institute of Medicine (IOM) National Healthcare Quality Report Categories</a></li>
                                    <li><a href="#442" class="section-mark">Identifying Information and Availability</a></li>
                                    <li><a href="#99999" class="section-mark">Disclaimer</a></li>
                            </ul>    
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
            </ul>

            <!-- Other -->
            <ul class="tools other-tools">
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Download</a>

                    <div class="dropdown-panel">
                        <ul>
                            <li><a href="/web/20180712210216/https://www.guideline.gov/summaries/downloadcontent/ngc-9990?contentType=pdf" class="pdf">.PDF 94.3 kb</a></li>
                            <li><a href="/web/20180712210216/https://www.guideline.gov/summaries/downloadcontent/ngc-9990?contentType=word" class="word">Word Document 283.1 kb</a></li>
                            <li><a href="/web/20180712210216/https://www.guideline.gov/summaries/downloadcontent/ngc-9990?contentType=xml" class="xml">.XML 34.6 kb</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Share</a>
                    <div class="dropdown-panel">
                        <ul class="toolbar-social">
                            <li><a target="_blank" href="https://web.archive.org/web/20180712210216/https://www.facebook.com/sharer/sharer.php?u=https://www.guideline.gov/summaries/summary/47061/inherited-thrombophilias-in-pregnancy" class="facebook">Facebook</a></li>
                            <li><a target="_blank" href="https://web.archive.org/web/20180712210216/https://twitter.com/share?text=&amp;url=https://www.guideline.gov/summaries/summary/47061/inherited-thrombophilias-in-pregnancy" class="twitter">Twitter</a></li>
                            <li><a target="_blank" href="https://web.archive.org/web/20180712210216/https://www.linkedin.com/shareArticle?mini=true&amp;url=https://www.guideline.gov/summaries/summary/47061/inherited-thrombophilias-in-pregnancy&amp;title=&amp;summary=&amp;source=" class="linkedin">Linkedin</a></li>
                            <li><a href="https://web.archive.org/web/20180712210216/mailto:/?Subject=AHRQ: Inherited thrombophilias in pregnancy.&amp;body=https://www.guideline.gov/summaries/summary/47061/inherited-thrombophilias-in-pregnancy" class="email">Email</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Cite</a>
                    <div class="dropdown-panel citation">
                        <p class="text-label"><label for="citation">Citation: </label></p>
                        <textarea id="citation">National Guideline Clearinghouse (NGC). Guideline summary: Inherited thrombophilias in pregnancy. In: National Guideline Clearinghouse (NGC) [Web site]. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); 2013 Sep 01. [cited 2018 Jul 12]. Available: https://www.guideline.gov</textarea>                        
                        <p class="text-label">Download citation file: </p>
                        <ul>
                            <li><a href="/web/20180712210216/https://www.guideline.gov/summaries/citedownload/47061?format=ris">RIS (Zotero)</a></li>
                            <li><a href="/web/20180712210216/https://www.guideline.gov/summaries/citedownload/47061?format=enw">EndNote</a></li>
                            <li><a href="/web/20180712210216/https://www.guideline.gov/summaries/citedownload/47061?format=bibtex">BibTex</a></li>
                            <li><a href="/web/20180712210216/https://www.guideline.gov/summaries/citedownload/47061?format=txt">Medlars</a></li>
                            <li><a href="/web/20180712210216/https://www.guideline.gov/summaries/citedownload/47061?format=ris">ProCite</a></li>
                            <li><a href="/web/20180712210216/https://www.guideline.gov/summaries/citedownload/47061">RefWorks</a></li>
                            <li><a href="/web/20180712210216/https://www.guideline.gov/summaries/citedownload/47061?format=ris">Reference Manager</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                                
                <li class="tool">
                        <a href="#" id="47061" data-alert="SignInLanding" class="tool-button save-link">Save</a>
                </li>
            </ul>

            <!-- Accordion -->
            <ul class="tools accordion-controls">
                <li class="tool"><a href="#" class="expand-all is-disabled" aria-disabled="true"><span class="screen-reader-text">Expand All</span></a></li>
                <li class="tool"><a href="#" class="collapse-all" aria-disabled="false"><span class="screen-reader-text">Collapse All</span></a></li>
            </ul>
        </div>
        <!-- /.toolbar -->


		<!-- ARTICLE -->
		<div class="article" id="article">
			




    <!-- ACCORDION -->
    <div class="accordion-container" role="tablist" multiselectable="true">
                <h2 id="420" class="accordion-title section-420 is-active" role="tab" aria-expanded="true"><a href="#">Recommendations</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Major Recommendations</a></h3>
                    <p><div class="content_para"><p>The grades of evidence (<strong>I-III</strong>) and levels of recommendations (<strong>A-C</strong>) are defined at the end of "Major Recommendations" field.</p>
<p><strong>The following recommendations are based on limited or inconsistent scientific evidence (Level B)</strong>:</p>
<ul style="list-style-type: disc;">
    <li>Warfarin, low-molecular-weight heparin (LMWH), and unfractionated heparin do not accumulate in breast milk and do not induce an anticoagulant effect in the infant; therefore, these anticoagulants may be used in women who breastfeed. </li>
    <li>Testing for inherited thrombophilias in women who have experienced recurrent fetal loss or placental abruption is not recommended because it is unclear if anticoagulation reduces recurrence. </li>
    <li>There is insufficient evidence to either screen for or treat women with inherited thrombophilias and obstetric histories that include complications such as fetal growth restriction or preeclampsia. </li>
    <li>Because of the lack of association between either heterozygosity or homozygosity for the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and any negative pregnancy outcomes, including any increased risk for venous thromboembolism, screening with either <em>MTHFR</em> mutation analyses or fasting homocysteine levels is not recommended. </li>
</ul>
<p><strong>The following recommendations are based primarily on consensus and expert opinion (Level C)</strong>:</p>
<ul style="list-style-type: disc;">
    <li>Recommended screening tests for inherited thrombophilias should include factor V Leiden mutation; prothrombin <em>G20210A</em> mutation; and antithrombin, protein C, and protein S deficiencies. </li>
    <li>Treatment recommendations for women with inherited thrombophilias are listed in the table below. </li>
    <li>All patients with inherited thrombophilias should undergo individualized risk assessment, which may modify management decisions. </li>
</ul>
<p><strong>Table: Recommended Thromboprophylaxis for Pregnancies Complicated by Inherited Thrombophilias*</strong></p>
<table border="1" cellspacing="1" cellpadding="3" summary="Table. Recommended Thromboprophylaxis for Pregnancies Complicated by Inherited Thrombophilias">
    <thead>
        <tr>
            <th class="Center" valign="top">Clinical Scenario</th>
            <th class="Center" valign="top">Antepartum Management</th>
            <th class="Center" valign="top">Postpartum Management</th>
        </tr>
    </thead>
    <tbody>
        <tr>
            <td valign="top">Low-risk thrombophilia&dagger; without previous VTE</td>
            <td valign="top">Surveillance without anticoagulation therapy</td>
            <td valign="top">Surveillance without anticoagulation therapy or postpartum anticoagulation therapy if the patient has additional risks factors&Dagger;</td>
        </tr>
        <tr>
            <td valign="top">Low-risk thrombophilia with a family history (first-degree relative) of VTE</td>
            <td valign="top">Surveillance without anticoagulation therapy </td>
            <td valign="top">Postpartum anticoagulation therapy&nbsp; or intermediate-dose LMWH/UFH</td>
        </tr>
        <tr>
            <td valign="top">Low-risk thrombophilia&dagger; with a single previous episode of VTE&mdash;Not receiving long-term anticoagulation</td>
            <td valign="top">Prophylactic or intermediate-dose LMWH/UFH or surveillance without anticoagulation therapy</td>
            <td valign="top">Postpartum anticoagulation therapy or intermediate-dose LMWH/UFH</td>
        </tr>
        <tr>
            <td valign="top">High-risk thrombophilia<sup>&sect;</sup> without previous VTE</td>
            <td valign="top">Surveillance without anticoagulation therapy or prophylactic LMWH or UFH</td>
            <td valign="top">Postpartum anticoagulation therapy</td>
        </tr>
        <tr>
            <td valign="top">High-risk thrombophilia<sup>&sect;</sup> with a single previous episode of VTE or an affected first-degree relative&mdash;Not receiving long-term anticoagulation therapy</td>
            <td valign="top">Prophylactic, intermediate-dose, or adjusted-dose LMWH/UFH regimen</td>
            <td valign="top">Postpartum anticoagulation therapy or intermediate or adjusted-dose LMWH/UFH for 6 weeks (therapy level should be at least as high as antepartum treatment)</td>
        </tr>
        <tr>
            <td valign="top">No thrombophilia with previous single episode of VTE associated with transient risk factor that is no longer present&mdash;Excludes pregnancy- or estrogen-related risk factor</td>
            <td valign="top">Surveillance without anticoagulation therapy</td>
            <td valign="top">Postpartum anticoagulation therapy<sup>||</sup></td>
        </tr>
        <tr>
            <td valign="top">No thrombophilia with previous single episode of VTE associated with transient risk factor that was pregnancy or estrogen related</td>
            <td valign="top">Prophylactic-dose LMWH or UFH<sup>||</sup></td>
            <td valign="top">Postpartum anticoagulation therapy</td>
        </tr>
        <tr>
            <td valign="top">No thrombophilia with previous single episode of VTE without an associated risk factor (idiopathic)&mdash;Not receiving long-term anticoagulation therapy </td>
            <td valign="top">Prophylactic LMWH or UFH<sup>||</sup></td>
            <td valign="top">Postpartum anticoagulation therapy</td>
        </tr>
        <tr>
            <td valign="top">Thrombophilia or no thrombophilia with two or more episodes of VTE&ndash;Not receiving long-term anticoagulation therapy</td>
            <td valign="top">Prophylactic or therapeutic-dose LMWH<br/>
            or<br/>
            Prophylactic or therapeutic-dose UFH </td>
            <td valign="top">Postpartum anticoagulation therapy<br/>
            or<br/>
            Therapeutic-dose LMWH/UFH for 6 weeks </td>
        </tr>
        <tr>
            <td valign="top">Thrombophilia or no thrombophilia with two or more episodes of VTE&ndash;Receiving long-term anticoagulation therapy</td>
            <td valign="top">Therapeutic-dose LMWH/UFH </td>
            <td valign="top">Resumption of long-term anticoagulation therapy</td>
        </tr>
    </tbody>
</table>
<p class="Note">Abbreviations: LMWH, low-molecular-weight heparin; UFH, unfractionated heparin; VTE, venous thromboembolism</p>
<p class="Note">*Postpartum treatment levels should be greater or equal to antepartum treatment. Treatment of acute VTE and management of antiphospholipid syndrome are addressed in other Practice Bulletins.</p>
<p class="Note"><sup>&dagger;</sup>Low-risk thrombophilia: factor V Leiden heterozygous; prothrombin <em>G20210A</em> heterozygous; protein C or protein S deficiency.</p>
<p class="Note"><sup>&Dagger;</sup>First-degree relative with a history of a thrombotic episode before age 50 years, or other major thrombotic risk factors (e.g., obesity, prolonged immobility).</p>
<p class="Note"><sup>&sect;</sup>High-risk thrombophilia: antithrombin deficiency; double heterozygous for prothrombin <em>G20210A</em> mutation and factor V Leiden; factor V Leiden homozygous or prothrombin <em>G20210A</em> mutation homozygous.</p>
<p class="Note"><sup>||</sup>Surveillance without anticoagulation is supported as an alternative approach by some experts.</p>
<p><strong><span style="text-decoration: underline;">Definitions</span></strong>:</p>
<p><strong>Grades of Evidence</strong></p>
<p><strong>I</strong> Evidence obtained from at least one properly designed randomized controlled trial.</p>
<p><strong>II-1</strong> Evidence obtained from well-designed controlled trials without randomization.</p>
<p><strong>II-2</strong> Evidence obtained from well-designed cohort or case&ndash;control analytic studies, preferably from more than one center or research group.</p>
<p><strong>II-3</strong> Evidence obtained from multiple time series with or without the intervention. Dramatic results in uncontrolled experiments also could be regarded as this type of evidence.</p>
<p><strong>III</strong> Opinions of respected authorities, based on clinical experience, descriptive studies, or reports of expert committees.</p>
<p><strong>Levels of Recommendations</strong></p>
<p><strong>Level A</strong>&mdash;Recommendations are based on good and consistent scientific evidence.</p>
<p><strong>Level B</strong>&mdash;Recommendations are based on limited or inconsistent scientific evidence.</p>
<p><strong>Level C</strong>&mdash;Recommendations are based primarily on consensus and expert opinion.</p></div></p>
                        <h3><a href="#">Clinical Algorithm(s)</a></h3>
                    <p><div class="content_para"><p>None provided</p></div></p>

            </div>
                <h2 id="396" class="accordion-title section-396 is-active" role="tab" aria-expanded="true"><a href="#">Scope</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Disease/Condition(s)</a></h3>
                    <p><ul style="list-style-type: disc;">
    <li>Inherited thrombophilias:
    <ul style="list-style-type: disc;">
        <li>Factor V Leiden mutation </li>
        <li>Prothrombin <em>G20210A</em> mutation </li>
        <li>Protein C deficiency </li>
        <li>Protein S deficiency </li>
        <li>Antithrombin deficiency </li>
        <li>Methylenetetrahydrofolate reductase mutations</li>
    </ul>
    </li>
    <li>Pregnancy </li>
    <li>Venous thromboembolism </li>
</ul></p>
                        <h3><a href="#">Guideline Category</a></h3>
                    <p>Evaluation</p>
                    <p>Management</p>
                    <p>Prevention</p>
                    <p>Risk Assessment</p>
                    <p>Screening</p>
                    <p>Treatment</p>
                        <h3><a href="#">Clinical Specialty</a></h3>
                    <p>Family Practice</p>
                    <p>Hematology</p>
                    <p>Medical Genetics</p>
                    <p>Obstetrics and Gynecology</p>
                    <p>Pharmacology</p>
                        <h3><a href="#">Intended Users</a></h3>
                    <p>Advanced Practice Nurses</p>
                    <p>Nurses</p>
                    <p>Physician Assistants</p>
                    <p>Physicians</p>
                        <h3><a href="#">Guideline Objective(s)</a></h3>
                    <p><div class="content_para"><p>To review common thrombophilias and their association with maternal venous thromboembolism risk and adverse pregnancy outcomes, indications for screening to detect these conditions, and management options in pregnancy</p></div></p>
                        <h3><a href="#">Target Population</a></h3>
                    <p><div class="content_para"><p>Pregnant, postpartum, and breastfeeding women with inherited thrombophilias</p></div></p>
                        <h3><a href="#">Interventions and Practices Considered</a></h3>
                    <p><div class="content_para"><p><strong>Risk Assessment/Screening</strong></p>
<ol style="list-style-type: decimal;">
    <li>Patient and family history </li>
    <li>Individualized risk assessment </li>
    <li>Screening for inherited thrombophilias:
    <ul style="list-style-type: disc;">
        <li>Factor V Leiden mutation </li>
        <li>Prothrombin <em>G20210A</em> mutation </li>
        <li>Protein C deficiency </li>
        <li>Protein S deficiency </li>
        <li>Antithrombin deficiency </li>
    </ul>
    </li>
</ol>
<p class="Note"><strong>Note</strong>: Screening with methylenetetrahydrofolate reductase (MTHFR) polymorphisms or measurement of fasting homocysteine levels was considered but not recommended.</p>
<p><strong>Management/Treatment</strong></p>
<ol style="list-style-type: decimal;">
    <li>Low-molecular-weight heparin (LMWH) </li>
    <li>Unfractionated heparin </li>
    <li>Warfarin </li>
    <li>Surveillance </li>
    <li>Compression stockings/pneumatic compression boots </li>
    <li>International normalized ratio (INR) monitoring </li>
</ol></div></p>
                        <h3><a href="#">Major Outcomes Considered</a></h3>
                    <p><ul style="list-style-type: disc;">
    <li>Incidence of venous thromboembolism </li>
    <li>Adverse pregnancy outcomes </li>
    <li>Adverse effects of therapy </li>
</ul></p>

            </div>
                <h2 id="405" class="accordion-title section-405 is-active" role="tab" aria-expanded="true"><a href="#">Methodology</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Methods Used to Collect/Select the Evidence</a></h3>
                    <p>Hand-searches of Published Literature (Primary Sources)</p>
                    <p>Hand-searches of Published Literature (Secondary Sources)</p>
                    <p>Searches of Electronic Databases</p>
                        <h3><a href="#">Description of Methods Used to Collect/Select the Evidence</a></h3>
                    <p><div class="content_para"><p>The MEDLINE database, the Cochrane Library, and the American College of Obstetricians and Gynecologists' own internal resources and documents were used to conduct a literature search to locate relevant articles published between January 1985 and January 2013. The search was restricted to articles published in the English language. Priority was given to articles reporting results of original research, although review articles and commentaries also were consulted. Abstracts of research presented at symposia and scientific conferences were not considered adequate for inclusion in this document. Guidelines published by organizations or institutions such as the National Institutes of Health and the American College of Obstetricians and Gynecologists were reviewed, and additional studies were located by reviewing bibliographies of identified articles. When reliable research was not available, expert opinions from obstetrician&ndash;gynecologists were used.</p></div></p>
                        <h3><a href="#">Number of Source Documents</a></h3>
                    <p><div class="content_para"><p>Not stated</p></div></p>
                        <h3><a href="#">Methods Used to Assess the Quality and Strength of the Evidence</a></h3>
                    <p>Weighting According to a Rating Scheme (Scheme Given)</p>
                        <h3><a href="#">Rating Scheme for the Strength of the Evidence</a></h3>
                    <p><div class="content_para"><p>Studies were reviewed and evaluated for quality according to the method outlined by the U.S. Preventive Services Task Force:</p>
<p><strong>I</strong> Evidence obtained from at least one properly designed randomized controlled trial.</p>
<p><strong>II-1</strong> Evidence obtained from well-designed controlled trials without randomization.</p>
<p><strong>II-2</strong> Evidence obtained from well-designed cohort or case&ndash;control analytic studies, preferably from more than one center or research group.</p>
<p><strong>II-3</strong> Evidence obtained from multiple time series with or without the intervention. Dramatic results in uncontrolled experiments also could be regarded as this type of evidence.</p>
<p><strong>III</strong> Opinions of respected authorities, based on clinical experience, descriptive studies, or reports of expert committees.</p></div></p>
                        <h3><a href="#">Methods Used to Analyze the Evidence</a></h3>
                    <p>Review of Published Meta-Analyses</p>
                    <p>Systematic Review</p>
                        <h3><a href="#">Description of the Methods Used to Analyze the Evidence</a></h3>
                    <p><div class="content_para"><p>Not stated</p></div></p>
                        <h3><a href="#">Methods Used to Formulate the Recommendations</a></h3>
                    <p>Expert Consensus</p>
                        <h3><a href="#">Description of Methods Used to Formulate the Recommendations</a></h3>
                    <p><div class="content_para"><p>Analysis of available evidence was given priority in formulating recommendations. When reliable research was not available, expert opinions from obstetrician-gynecologists were used. See also the "Rating Scheme for the Strength of the Recommendations" field regarding Level C recommendations.</p></div></p>
                        <h3><a href="#">Rating Scheme for the Strength of the Recommendations</a></h3>
                    <p><div class="content_para"><p>Based on the highest level of evidence found in the data, recommendations are provided and graded according to the following categories:</p>
<p><strong>Level A</strong> &mdash; Recommendations are based on good and consistent scientific evidence.</p>
<p><strong>Level B</strong> &mdash; Recommendations are based on limited or inconsistent scientific evidence.</p>
<p><strong>Level C</strong> &mdash; Recommendations are based primarily on consensus and expert opinion.</p></div></p>
                        <h3><a href="#">Cost Analysis</a></h3>
                    <p><div class="content_para"><p>A formal cost analysis was not performed and published cost analyses were not reviewed.</p></div></p>
                        <h3><a href="#">Method of Guideline Validation</a></h3>
                    <p>Internal Peer Review</p>
                        <h3><a href="#">Description of Method of Guideline Validation</a></h3>
                    <p><div class="content_para"><p>Practice Bulletins are validated by two internal clinical review panels composed of practicing obstetrician-gynecologists generalists and sub-specialists. The final guidelines are also reviewed and approved by the American College of Obstetricians and Gynecologists (ACOG) Executive Board.</p></div></p>

            </div>
                <h2 id="424" class="accordion-title section-424 is-active" role="tab" aria-expanded="true"><a href="#">Evidence Supporting the Recommendations</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Type of Evidence Supporting the Recommendations</a></h3>
                    <p><div class="content_para"><p>The type of supporting evidence is identified and graded for each recommendation (see the "Major Recommendations" field).</p></div></p>

            </div>
                <h2 id="427" class="accordion-title section-427 is-active" role="tab" aria-expanded="true"><a href="#">Benefits/Harms of Implementing the Guideline Recommendations</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Potential Benefits</a></h3>
                    <p><ul style="list-style-type: disc;">
    <li>Appropriate management of inherited thrombophilias in pregnancy </li>
    <li>Decreased maternal venous thromboembolism risk </li>
    <li>Reduction of adverse pregnancy outcomes such as fetal loss, preeclampsia, fetal growth restriction, and placental abruption </li>
</ul></p>
                        <h3><a href="#">Potential Harms</a></h3>
                    <p><ul style="list-style-type: disc;">
    <li>Bleeding risks associated with anticoagulation therapy </li>
    <li>To avoid paradoxical thrombosis and skin necrosis from the early antiprotein C effect of warfarin, women should continue to take therapeutic doses of unfractionated heparin or low-molecular-weight heparin (LMWH) for 5 days and until the international normalized ratio (INR) is therapeutic (2.0&ndash;3.0) for 2 consecutive days. </li>
</ul></p>

            </div>
                <h2 id="432" class="accordion-title section-432 is-active" role="tab" aria-expanded="true"><a href="#">Qualifying Statements</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Qualifying Statements</a></h3>
                    <p><div class="content_para"><p>The information is designed to aid practitioners in making decisions about appropriate obstetric and gynecologic care. These guidelines should not be construed as dictating an exclusive course of treatment or procedure. Variations in practice may be warranted based on the needs of the individual patient, resources, and limitations unique to the institution or type of practice.</p></div></p>

            </div>
                <h2 id="434" class="accordion-title section-434 is-active" role="tab" aria-expanded="true"><a href="#">Implementation of the Guideline</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Description of Implementation Strategy</a></h3>
                    <p><div class="content_para"><p>An implementation strategy was not provided.</p></div></p>
                        <h3><a href="#">Implementation Tools</a></h3>
                    <p>Audit Criteria/Indicators</p>
                    <p><div class="general-block">For information about availability, see the <i>Availability of Companion Documents</i> and <i>Patient Resources</i> fields below.</div></p>

            </div>
                <h2 id="439" class="accordion-title section-439 is-active" role="tab" aria-expanded="true"><a href="#">Institute of Medicine (IOM) National Healthcare Quality Report Categories</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">IOM Care Need</a></h3>
                    <p>Living with Illness</p>
                    <p>Staying Healthy</p>
                        <h3><a href="#">IOM Domain</a></h3>
                    <p>Effectiveness</p>

            </div>
                <h2 id="442" class="accordion-title section-442 is-active" role="tab" aria-expanded="true"><a href="#">Identifying Information and Availability</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Bibliographic Source(s)</a></h3>
                    <p><table><tr><td>American College of Obstetricians and Gynecologists (ACOG). Inherited thrombophilias in pregnancy. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 2013 Sep. 12 p.&nbsp;(ACOG practice bulletin; no. 138).&nbsp; [69 references]</td></tr></table></p>
                        <h3><a href="#">Adaptation</a></h3>
                    <p><div class="content_para"><p>Not applicable: The guideline was not adapted from another source.</p></div></p>
                        <h3><a href="#">Date Released</a></h3>
                    <p>2010 Apr (revised 2013 Sep)</p>
                        <h3><a href="#">Guideline Developer(s)</a></h3>
                    <p>American College of Obstetricians and Gynecologists - Medical Specialty Society</p>
                        <h3><a href="#">Source(s) of Funding</a></h3>
                    <p><div class="content_para"><p>American College of Obstetricians and Gynecologists (ACOG)</p></div></p>
                        <h3><a href="#">Guideline Committee</a></h3>
                    <p><div class="content_para"><p>American College of Obstetricians and Gynecologists (ACOG) Committee on Practice Bulletins&mdash;Obstetrics</p></div></p>
                        <h3><a href="#">Composition of Group That Authored the Guideline</a></h3>
                    <p><div class="content_para"><p>This Practice Bulletin was developed by the Committee on Practice Bulletins&mdash;Obstetrics with the assistance of Charles Lockwood, MD, George Wendel, MD, and Neil Silverman, MD.</p>
<p>American College of Obstetricians and Gynecologists (ACOG) committees are created or abolished and their overall function defined by the Executive Board. Appointments are made for one year, with the understanding that such appointment may be continued for a total of three years. The majority of committee members are Fellows, but Junior Fellows also are eligible for appointment. Some committees may have representatives from other organizations when this is particularly appropriate to committee activities. The president elect appoints committee members annually.</p></div></p>
                        <h3><a href="#">Financial Disclosures/Conflicts of Interest</a></h3>
                    <p><div class="content_para"><p>Not stated</p></div></p>
                        <h3><a href="#">Guideline Status</a></h3>
                    <p><div class="content_para"><p>This is the current release of the guideline.</p>
<p>This guideline updates a previous version: American College of Obstetricians and Gynecologists (ACOG). Inherited thrombophilias in pregnancy. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 2011 Sep. 11 p. (ACOG practice bulletin; no. 124). [66 references]</p></div></p>
                        <h3><a href="#">Guideline Availability</a></h3>
                    <p><div class="content_para"><p>No electronic copies available</p>
<p>Print copies: Available for purchase from the American College of Obstetricians and Gynecologists (ACOG) Distribution Center, PO Box 933104, Atlanta, GA 31193-3104; telephone, 800-762-2264; e-mail: <a href="https://web.archive.org/web/20180712210216/mailto:sales@acog.org">sales@acog.org</a>. The ACOG Bookstore is available online at the <a href="/web/20180712210216/https://www.guideline.gov/Home/Disclaimer?id=47061&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.acog.org%2fbookstore%2f" title="ACOG Bookstore Web site">ACOG Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712210216im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>.</p></div></p>
                        <h3><a href="#">Availability of Companion Documents</a></h3>
                    <p><div class="content_para"><p>A proposed performance measure is included in the original guideline document.</p></div></p>
                        <h3><a href="#">Patient Resources</a></h3>
                    <p><div class="content_para"><p>None available</p></div></p>
                        <h3><a href="#">NGC Status</a></h3>
                    <p><div class="content_para"><p>This NGC summary was completed by ECRI Institute on September 16, 2010. This NGC summary was updated by ECRI Institute on October 21, 2011. This NGC summary was updated by ECRI Institute on October 25, 2013. This summary was updated by ECRI Institute on March 10, 2014 following the U.S. Food and Drug Administration advisory on Low Molecular Weight Heparins.</p></div></p>
                        <h3><a href="#">Copyright Statement</a></h3>
                    <p><div class="content_para"><p>This NGC summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions.</p></div></p>

            </div>
                <h2 id="99999" class="accordion-title section-99999 is-active" role="tab" aria-expanded="true"><a href="#">Disclaimer</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">NGC Disclaimer</a></h3>
                    <p><p>The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.</p> 
<p>All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.</p> 
<p>Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the <a href="/web/20180712210216/https://www.guideline.gov/help-and-about/summaries/inclusion-criteria">NGC Inclusion Criteria</a>.</p> 
<p>NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.</p> 
<p>Readers with questions regarding guideline content are directed to contact the guideline developer.</p></p>

            </div>

    </div>
    <!-- /.accordion-container -->

<!-- ASIDE -->
<!-- FOOTER -->






		</div><!-- /.article -->

	</div><!-- /.content -->

	
			<div class="aside">
				

    <!-- About NGC -->
    <div class="info-block">
            <h3 class="info prefix-icon large-icon">About NGC Guideline Summaries</h3>
            <p>NGC provides structured summaries containing information from clinical practice guidelines.</p>
            <ul>
                <li><a href="/web/20180712210216/https://www.guideline.gov/help-and-about/summaries/inclusion-criteria" class="internal-link">Inclusion Criteria</a></li>
                <li><a href="/web/20180712210216/https://www.guideline.gov/help-and-about/summaries/template-of-guideline-attributes" class="internal-link">Template of Guideline Attributes</a></li>
                <li><a href="/web/20180712210216/https://www.guideline.gov/help-and-about/summaries/classification-scheme" class="internal-link">Classification Scheme</a></li>
            </ul>
            <p><a href="/web/20180712210216/https://www.guideline.gov/help-and-about/summaries/faqs" class="help-button">Guideline Summary FAQs</a></p>

    </div>
    <!-- /info-block -->

    <!-- Guideline Synthesis -->

    <!-- HHS Block -->

    <!-- Related Content -->


    <hr>

    <!-- New on NGC -->
    <div class="subscribe-header">
        <h3 class="subscribe-title">New on NGC</h3>
        <ul class="subscribe-links">
            <li><a href="/web/20180712210216/https://www.guideline.gov/subscribe" class="newsletter"><span class="subscribe-links-label">Get Email Alerts</span></a></li>
            <li><a href="/web/20180712210216/https://www.guideline.gov/rssFiles/ngc_newthisweek.xml" class="rss"><span class="subscribe-links-label">RSS Feed</span></a></li>
        </ul>
    </div>
    <!-- /.subscribe-header -->
        <h5 class="prefix-icon guideline news-list-category-label">Guideline Summaries</h5>
        <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011378</li>
            <li>2017 Oct</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712210216/https://www.guideline.gov/summaries/summary/51300/mental-health-care-in-the-perinatal-period-australian-clinical-practice-guideline">Mental health care in the perinatal period: Australian clinical practice guideline.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011372</li>
            <li>2015</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712210216/https://www.guideline.gov/summaries/summary/51294/clinical-practice-guideline-on-systemic-lupus-erythematosus">Clinical practice guideline on systemic lupus erythematosus.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011385</li>
            <li>2018 Mar</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712210216/https://www.guideline.gov/summaries/summary/51326/vadod-clinical-practice-guideline-for-the-management-of-pregnancy">VA/DoD clinical practice guideline for the management of pregnancy.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011376</li>
            <li>2018 Feb</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712210216/https://www.guideline.gov/summaries/summary/51298/clinical-pharmacogenetics-implementation-consortium-cpic-guideline-for-dihydropyrimidine-dehydrogenase-genotype-and-fluoropyrimidine-dosing-2017-update">Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing: 2017 update.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011370</li>
            <li>2017 Dec</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712210216/https://www.guideline.gov/summaries/summary/51292/the-implementation-of-targeted-temperature-management-an-evidencebased-guideline-from-the-neurocritical-care-society">The implementation of targeted temperature management: an evidence-based guideline from the Neurocritical Care Society.</a></p>
    </div>

    <a class="block-link" href="/web/20180712210216/https://www.guideline.gov/new-this-week/index">
        <h3>New This Week </h3>
        <p>View more and sign up for our Newsletter</p>
    </a>
    <!-- Adobe Reader -->
    <p><a href="/web/20180712210216/https://www.guideline.gov/disclaimer?id=47061&amp;contentType=summary&amp;redirect=http%3A%2F%2Fget.adobe.com%2Freader%2F" class="external-link">Get Adobe Reader</a></p>

			</div><!-- /.aside -->
		</div><!-- /.aside-container -->

	<!-- BACK TO TOP -->
	
	
	



    <!-- COMMENTS -->
    

</div><!-- /.main -->

	</main>

	<!-- FOOTER -->
	<div class="footer" id="footer">

		<div class="footer-grid-container">
			<!-- Header -->
			<div class="footer-header">
				<a href="#" class="footer-logo">
			 		<picture>
					  	<source type="image/svg+xml" srcset="/web/20180712210216im_/https://www.guideline.gov/UI/images/logo_NGC_footer.svg">
					  	<img src="/web/20180712210216im_/https://www.guideline.gov/UI/images/logo_NGC_footer.png" alt="NGC">
					</picture>
				</a>
			</div><!-- /.footer-header -->

			<!-- Content -->
			<div class="footer-content">
				<div class="footer-nav">
					<ul class="level-1">
						<li><a href="/web/20180712210216/https://www.guideline.gov/">Home</a></li>
		                <li><a href="/web/20180712210216/https://www.guideline.gov/new-this-week/index">New This Week</a></li>
						<li><a href="/web/20180712210216/https://www.guideline.gov/browse/organization" class="parent-link">Guideline Summaries</a></li>
<li><a href="/web/20180712210216/https://www.guideline.gov/syntheses/index">Guideline Syntheses</a></li>						<li><a href="/web/20180712210216/https://www.guideline.gov/expert">Expert Commentaries</a></li>
		                <li><a href="/web/20180712210216/https://www.guideline.gov/matrix">Matrix Tool</a></li>
						<li><a href="/web/20180712210216/https://www.guideline.gov/summaries/submit">Submit Guidelines</a></li>
						<li><a href="/web/20180712210216/https://www.guideline.gov/help-and-about">Help &amp;&nbsp;About</a></li>
					</ul>
					<ul class="level-2">
						<li><a href="/web/20180712210216/https://www.guideline.gov/contact-us">Contact Us</a></li>
						<li><a href="/web/20180712210216/https://www.guideline.gov/rss">RSS</a></li>
					    <li><a href="/web/20180712210216/https://www.guideline.gov/site-map">Site Map</a></li>
                        <li><a href="/web/20180712210216/https://www.guideline.gov/browse/related">Related NQMC Measures</a></li>
                        <li><a href="/web/20180712210216/https://www.guideline.gov/help-and-about/about/editorial-board">Editorial Board</a></li>
                        <li><a href="/web/20180712210216/https://www.guideline.gov/help-and-about/general/web-site-credits">Web Site Credits</a></li>
                        <li><a href="/web/20180712210216/https://www.guideline.gov/help-and-about/general/disclaimer">Disclaimer</a></li>
						<li><a href="/web/20180712210216/https://www.guideline.gov/help-and-about/general/privacy">Privacy Policy</a></li>
                        <li><a href="/web/20180712210216/https://www.guideline.gov/help-and-about/technical/accessibility">Accessibility</a></li>	
                        <li><a href="/web/20180712210216/https://www.guideline.gov/help-and-about/technical/for-web-developers">For Web Developers</a></li>
					</ul>
				</div><!-- /.footer-nav -->
			</div><!-- /.footer-content -->

			<!-- Aside -->
			<div class="footer-aside">
				<h5 class="footer-partner-link-header">Visit our partner sites</h5>
				<ul class="footer-partner-links">
				    <li><!-- NQMC footer link -->
						<a href="https://web.archive.org/web/20180712210216/https://www.qualitymeasures.ahrq.gov/" target="_blank" class="partner-button nqmc">
							<span class="partner-logo">
								<picture>
							    	<source type="image/svg+xml" srcset="/web/20180712210216im_/https://www.guideline.gov/UI/images/logo_footerlink_nqmc.svg">
									<img src="/web/20180712210216im_/https://www.guideline.gov/UI/images/logo_footerlink_nqmc.png" alt="National Quality Measures Clearinghouse"/>
								</picture>
							</span>
						</a>
					</li><!--/MQMC footer Link -->
					<li><!-- HHS footer link --> 
						<a href="https://web.archive.org/web/20180712210216/https://www.qualitymeasures.ahrq.gov/hhs/index.aspx" target="_blank" class="partner-button hhs">
							<span class="partner-logo">
								<picture>
								    <source type="image/svg+xml" srcset="/web/20180712210216im_/https://www.guideline.gov/UI/images/logo_footerlink_hmis.svg">
								    <img src="/web/20180712210216im_/https://www.guideline.gov/UI/images/logo_footerlink_hmis.png" alt="HHS Measures Inventory"/>
								</picture>
							</span>
						</a>
					</li><!--/HHS footer link -->
				</ul>
			</div><!-- /.footer-aside -->

		</div><!-- /.footer-grid-container -->

	</div><!-- /.footer -->

	
	<!-- AHRQ FOOTER -->
	<div id="ahrq-footer">

		<!-- FIRST -->
		<div class="ahrq-first-footer">
			<div class="column">
			<div class="ahrq-footer-grid-container">
				<div class="ahrq-footer-left">
					<p><a href="https://web.archive.org/web/20180712210216/http://www.ahrq.gov/index.html" class="ahrq-footer-logo" target="_blank">AHRQ</a></p>
				</div><!-- /.ahrq-footer-left -->
				<div class="ahrq-footer-center">
					<ul>
						<li><a href="https://web.archive.org/web/20180712210216/http://www.ahrq.gov/policy/electronic/accessibility/index.html" target="_blank">Accessibility</a></li>
						<li><a href="https://web.archive.org/web/20180712210216/http://www.ahrq.gov/policy/electronic/disclaimers/index.html" target="_blank">Disclaimers</a></li>
						<li><a href="https://web.archive.org/web/20180712210216/http://www.ahrq.gov/policy/eeo/index.html" target="_blank">EEO</a></li>
						<li><a href="https://web.archive.org/web/20180712210216/http://www.ahrq.gov/policy/foia/index.html" target="_blank">FOIA</a></li>
						<li><a href="https://web.archive.org/web/20180712210216/http://www.hhs.gov/web/governance/digital-strategy/index.html" target="_blank">HHS Digital Strategy</a></li>
						<li><a href="https://web.archive.org/web/20180712210216/http://oig.hhs.gov/" target="_blank">Inspector General</a></li>
						<li><a href="https://web.archive.org/web/20180712210216/http://www.ahrq.gov/policy/electronic/plain-writing/index.html" target="_blank">Plain Writing Act</a></li>
						<li><a href="https://web.archive.org/web/20180712210216/http://www.ahrq.gov/policy/electronic/privacy/index.html" target="_blank">Privacy Policy</a></li>
						<li><a href="https://web.archive.org/web/20180712210216/http://www.ahrq.gov/policy/electronic/about/policyix.html" target="_blank">Electronic Policies</a></li>
						<li><a href="https://web.archive.org/web/20180712210216/http://www.hhs.gov/plugins.html" target="_blank">Viewers &amp; Players</a></li>
					</ul>
				</div><!-- /.ahrq-footer-center -->
				<div class="ahrq-footer-right">
					<h3>Get Social</h3>
					<ul class="ahrq-social">
						<li><a href="https://web.archive.org/web/20180712210216/http://www.facebook.com/" target="_blank" class="facebook"><span class="screen-reader-text">Facebook</span></a></li>
						<li><a href="https://web.archive.org/web/20180712210216/http://www.twitter.com/" target="_blank" class="twitter"><span class="screen-reader-text">Twitter</span></a></li>
						<li><a href="https://web.archive.org/web/20180712210216/http://www.linkedin.com/" target="_blank" class="linkedin"><span class="screen-reader-text">LinkedIn</span></a></li>
						<li><a href="https://web.archive.org/web/20180712210216/http://www.youtube.com/" target="_blank" class="youtube"><span class="screen-reader-text">YouTube</span></a></li>
					</ul>
				</div><!-- /.ahrq-footer-right -->
			</div><!-- /.ahrq-footer-grid-container -->
			</div><!-- /.column -->
		</div><!-- /.first-footer -->

		<!-- SECOND -->
		<div class="ahrq-second-footer">
			<div class="column">
			<div class="ahrq-footer-grid-container">
				<div class="ahrq-footer-left">
					<ul>
						<li><a href="https://web.archive.org/web/20180712210216/http://www.ahrq.gov/index.html" target="_blank" class="ahrq-footer-home-link"><span class="screen-reader-text">AHRQ Home</span></a></li>
						<li><a href="https://web.archive.org/web/20180712210216/http://www.ahrq.gov/cpi/about/index.html" target="_blank">About Us</a></li>
						<li><a href="https://web.archive.org/web/20180712210216/http://www.ahrq.gov/cpi/about/careers/index.html" target="_blank">Careers</a></li>
						<li><a href="https://web.archive.org/web/20180712210216/http://www.ahrq.gov/contact/index.html" target="_blank">Contact Us</a></li>
						<li><a href="https://web.archive.org/web/20180712210216/http://www.ahrq.gov/Sitemap.html" target="_blank">Sitemap</a></li>
						<li><a href="https://web.archive.org/web/20180712210216/https://info.ahrq.gov/" target="_blank">FAQ</a></li>
					</ul>	
				</div><!-- /.ahrq-footer-left -->
				<div class="ahrq-footer-center">
					<ul>
						<li><a href="https://web.archive.org/web/20180712210216/http://www.ahrq.gov/health-care-information/index.html" target="_blank">Health Care Information</a></li>
						<li><a href="https://web.archive.org/web/20180712210216/http://www.ahrq.gov/patients-consumers/index.html" target="_blank">For Patients &amp; Consumers</a></li>
						<li><a href="https://web.archive.org/web/20180712210216/http://www.ahrq.gov/professionals/index.html" target="_blank">For Professionals</a></li>
						<li><a href="https://web.archive.org/web/20180712210216/http://www.ahrq.gov/policymakers/index.html" target="_blank">For Policymakers</a></li>
						<li><a href="https://web.archive.org/web/20180712210216/http://www.ahrq.gov/research/index.html" target="_blank">Research Tools &amp; Data</a></li>
						<li><a href="https://web.archive.org/web/20180712210216/http://www.ahrq.gov/funding/index.html" target="_blank">Funding &amp; Grants</a></li>
						<li><a href="https://web.archive.org/web/20180712210216/http://www.ahrq.gov/cpi/index.html" target="_blank">Offices, Centers &amp; Programs</a></li>
						<li><a href="https://web.archive.org/web/20180712210216/http://www.ahrq.gov/news/index.html" target="_blank">News &amp; Events</a></li>
					</ul>
				</div><!-- /.ahrq-footer-center -->
				<div class="ahrq-footer-right">
					<ul>
						<li><a href="https://web.archive.org/web/20180712210216/http://www.hhs.gov/" target="_blank">U.S. Department of Health &amp; Human Services</a></li>
						<li><a href="https://web.archive.org/web/20180712210216/http://www.whitehouse.gov/" target="_blank">The White House</a></li>
						<li><a href="https://web.archive.org/web/20180712210216/http://www.usa.gov/" target="_blank">USA.gov: The U.S. Government's Official Web Portal   </a></li>
					</ul>
					<p class="ahrq-address">
						<strong>Agency for Healthcare Research&nbsp;and&nbsp;Quality</strong>
					    <br/>5600 Fishers Lane
					    <br/>Rockville, MD 20857
					    <br/><strong>Telephone:</strong> (301) 427-1364
					</p>
				</div><!-- /.ahrq-footer-right -->
			</div><!-- /.ahrq-footer-grid-container -->
			</div><!-- /.column -->
		</div><!-- /.second-footer -->
	</div><!-- /#ahrq-footer -->


	
	<!-- SCRIPTS -->
	
<script src="//web.archive.org/web/20180712210216js_/https://ajax.googleapis.com/ajax/libs/jquery/1.6.3/jquery.min.js" type="text/javascript"></script>
<script type="text/javascript">
if(!window.jQuery){
document.write('<script src="/cassette.axd/script/cdd67f922f9d413eaccb759182297335f87c3ff7/UI/js/jquery.js" type="text/javascript"><\/script>');
}
</script>
<script src="/web/20180712210216js_/https://www.guideline.gov/cassette.axd/script/595952c286b7fd52f0737b6f62085709be93156a/bodyJS" type="text/javascript"></script>

    
</body>
</html>
<!--
     FILE ARCHIVED ON 21:02:16 Jul 12, 2018 AND RETRIEVED FROM THE
     INTERNET ARCHIVE ON 16:53:57 Jul 15, 2018.
     JAVASCRIPT APPENDED BY WAYBACK MACHINE, COPYRIGHT INTERNET ARCHIVE.

     ALL OTHER CONTENT MAY ALSO BE PROTECTED BY COPYRIGHT (17 U.S.C.
     SECTION 108(a)(3)).
-->
<!--
playback timings (ms):
  LoadShardBlock: 514.597 (3)
  esindex: 0.006
  captures_list: 534.354
  CDXLines.iter: 15.774 (3)
  PetaboxLoader3.datanode: 214.313 (4)
  exclusion.robots: 0.167
  exclusion.robots.policy: 0.156
  RedisCDXSource: 0.663
  PetaboxLoader3.resolve: 303.798 (3)
  load_resource: 40.743
-->